Vanguard Global Advisers
KRRO icon

Vanguard Global Advisers’s Korro Bio KRRO Stock Holding History

Vanguard Global Advisers’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.4K Hold
1,929
– – ﹤0.01% 3268
2026
Q1 		$21.8K Buy
+1,929
New +$21.2K ﹤0.01% 3281

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Global Advisers's KRRO Position: Q2 2026 in Review

Vanguard Global Advisers held its Korro Bio (KRRO) position steady in Q2 2026 at 1,929 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3268.

Vanguard Global Advisers first reported a position in KRRO in Q1 2026 and has held it in 2 quarters since. 97 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Vanguard Global Advisers held 1,929 shares of Korro Bio worth $25.4K as of Q2 2026.
  • Vanguard Global Advisers left its Korro Bio share count unchanged in Q2 2026.
  • Korro Bio made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3268 holding.
  • Vanguard Global Advisers first reported a position in Korro Bio in Q1 2026 and has held it in 2 quarters since.
  • 97 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.